InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
17%
T+90 mean return
-7.5%
Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Scanlon Meghan, Vice-Présidente Senior, Présidente Urologie Santé Pelvique et Administratrice. Director active across 2 companies, notably Boston Scientific CORP. In total, 18 disclosures have been recorded. History available since 1 May 2021. The latest transaction was filed on 17 May 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations18 total
42,113 sharesCommon StockSEC:0000950170-25-056369:0
15,906 shares0Common StockSEC:0001610717-24-000251:0
8,361 shares0Common StockSEC:0001610717-23-000056:0
2,062 shares0Common StockSEC:0001225208-22-006331:0
17,846 shares0Common StockSEC:0001567619-22-008111:0
1,019 shares0Common StockSEC:0001225208-22-003868:0
779 shares0Common StockSEC:0001225208-22-003088:0
1,583 shares0Common StockSEC:0001225208-22-002933:0
1,108 shares0Common StockSEC:0001225208-22-002699:0
1,108 shares0Common StockSEC:0001225208-22-002699
13,850 shares@ US$23.4126.8% of flowCommon StockSEC:0001225208-21-010901
13,850 shares@ US$23.410.0002% mcap26.8% of flowCommon StockSEC:0001225208-21-010901:0
855 shares0Common StockSEC:0001225208-21-010279
855 shares0Common StockSEC:0001225208-21-010279:0
16,450 shares@ US$17.2623.2% of flowCommon StockSEC:0001225208-21-009606
16,450 shares@ US$17.260.0002% mcap23.2% of flowCommon StockSEC:0001225208-21-009606:0
2,061 shares0Common StockSEC:0001225208-21-007475
2,061 shares0Common StockSEC:0001225208-21-007475:0
18 of 18 declarations
About Scanlon Meghan
Meghan Scanlon is an executive at BOSTON SCIENTIFIC CORP.
